Updated:
Kardia
Kardia is a Calgary-based private equity firm focused on early-stage and growth venture investments in Western Canada.
Kardia
Welcome to Kardia We are an impact driven and heart centred boutique management consulting firm, with a global reach. We are committed to creating responsible communities that are socially accountable, environmentally sustainable and promote economic growth. We unlock the full potential of our communities by...
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Calgary
Corporate office
Calgary, AB, Canada
Frequently asked questions
What is Kardia's investment strategy?
Kardia describes its strategy as early-stage venture and growth equity, targeting startup and expansion-stage companies. The firm operates with a generalist mandate, which typically allows it to evaluate opportunities across multiple sectors. No further detail on stage check sizes, target ownership percentages, or reserve strategies is publicly available.
Who runs Kardia's investment decisions?
The identities of Kardia's principals, investment committee members, and portfolio managers do not appear in any source captured for this profile. No executive biographies, board appointments, or media mentions naming Kardia's leadership have been identified. This is common among smaller private-capital firms that do not actively seek institutional press.
Where does Kardia's capital come from?
Kardia's funding sources are undisclosed. Canadian private equity firms of this profile may raise capital from high-net-worth individuals, family offices, institutional limited partners, or government-affiliated funds of funds such as those managed by Alberta Enterprise Corporation. No specific backer relationships have been confirmed.
Does Kardia focus exclusively on Alberta-based companies?
The firm's headquarters in Calgary suggests a strong orientation toward Western Canadian deal flow, but no publicly stated geographic mandate confirms or rules out investments elsewhere in Canada or the United States. Without a named portfolio, the geographic scope remains inferred rather than observed.
What is Kardia's known posture on co-investments alongside external GPs?
No co-investment partnerships, club deals, or syndication patterns involving Kardia have been documented in public records. For Canadian venture-stage firms, co-investment is a common practice, but Kardia's specific approach cannot be verified.
Has Kardia announced any recent fund closes?
No fund closes, capital raises, or regulatory filings referencing Kardia have been identified in the 2024–2026 period. This may reflect a quiet period, a deal-by-deal capital-raising model, or limited public disclosure.
How can institutional allocators conduct diligence on Kardia given the limited public record?
Allocators would need to engage Kardia directly to review track record, team composition, fund documentation, and audited financial statements. The absence of a website scrape or LinkedIn profile in the research record makes primary outreach the only viable diligence path for institutional evaluation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: